Sign In
Buy BAX
$19.35
+0.81 (+4.37%)
At Close: Jun 04, 2026
Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina
06:07pm, Monday, 30'th Sep 2024
Baxter International Inc BAX. has shut down its largest manufacturing facility following significant damage caused by Hurricane Helene.
Baxter Shares May Gain on the Launch of Its Latest Vest APX System
10:45am, Monday, 30'th Sep 2024
BAX launches its next-generation airway clearance system, The Vest APX System, for chronic lung conditions.
Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community
04:00pm, Sunday, 29'th Sep 2024
DEERFIELD, Ill.--(BUSINESS WIRE)---- $BAX--Baxter International Inc. (NYSE:BAX), a global medtech leader, today shared updates regarding the impact of Hurricane Helene, which brought unprecedented rai
Baxter Launches Next Generation of The Vest System for Airway Clearance
07:30am, Thursday, 26'th Sep 2024
BOSTON--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance system, The Vest Advanced Pulmonary Experience (APX
4 Medical Product Stocks to Buy From a Prospective Industry
09:11am, Tuesday, 24'th Sep 2024
Ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, BAX, HAE and PAHC are well-poised to gain from the favorable factors
5 Incredible Healthcare High-Yield Blue-Chip Bargain Buys For 2025
07:00am, Thursday, 19'th Sep 2024
Healthcare is undervalued despite being the top sector for earnings growth, making it an attractive investment with solid fundamentals and the potential for explosive returns in 2025. Investing in hea
Baxter (BAX) Upgraded to Buy: Here's Why
01:05pm, Monday, 16'th Sep 2024
Baxter (BAX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BAX vs. PODD: Which Stock Should Value Investors Buy Now?
12:46pm, Monday, 16'th Sep 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Insulet (PODD). But which of these two stocks is more attractive to valu
Is Baxter International (BAX) Stock Undervalued Right Now?
10:47am, Monday, 16'th Sep 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Broyhill's Q2 2024 Top Five Investments
04:00am, Friday, 13'th Sep 2024
Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in Ju
Baxter Appoints Jeffrey A. Craig to Its Board
09:00am, Monday, 09'th Sep 2024
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Jeffrey (Jay) A. Craig, former executive chair and chief executive off
Spectral Medical Provides August Tigris Trial Update
07:30am, Tuesday, 03'rd Sep 2024
Management provides view on recently announced Vantive-Carlyle Group transaction Management provides view on recently announced Vantive-Carlyle Group transaction
Baxter International (BAX) Recently Broke Out Above the 200-Day Moving Average
10:31am, Tuesday, 27'th Aug 2024
From a technical perspective, Baxter International (BAX) is looking like an interesting pick, as it just reached a key level of support. BAX recently overtook the 200-day moving average, and this sugg
Baxter To Sell Its Kidney Care Unit To Carlyle For $3.8 Billion
04:15pm, Monday, 19'th Aug 2024
On August 13, 2024, Baxter International Inc. (NYSE: BAX, $36.12, Market Capitalization: $18.4 billion), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ: CG) annou
Baxter To Sell Its Kidney Care Unit To Carlyle For $3.8 Billion
04:15pm, Monday, 19'th Aug 2024
On August 13, 2024, Baxter International Inc. (NYSE: BAX, $36.12, Market Capitalization: $18.4 billion), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ: CG) annou
